Presentation on Global Health Challenges with Bill Gates Official Side Event of the 8th Tokyo International Conference on African Development (TICAD8)

  • Share
  • Tweet
  • Share
  • Tweet

August 25, 2022

The Volunteer Group of Business Leaders Supporting Global Health, in which Eisai participates, held an official side event "Global Health Action Japan - Japanese Companies' Activities to Raise the Level of Global Health" on August 19, 2022 in Tokyo, prior to TICAD8 to be held in Tunisia over two days from August 27, 2022. Special guest speaker Bill Gates, co-chair of the Bill & Melinda Gates Foundation, also participated in the event and led a session on further contribution from the private sector in the Global health field.

Sayoko Sasaki, Eisai’s Vice President in charge of ESG, gave a presentation titled "Business Domain Guided by hhc Concept". The presentation highlighted our activities to eliminate neglected tropical diseases (NTDs), including the free provision of lymphatic filariasis treatment, comprehensive support in endemic areas through disease awareness and the provision of clean water, as well as efforts to develop a new drug to treat mycetoma.

For videos of the event, please click here
For detailed information of the event, please click here (in Japanese only)

Eisai’s initiatives for improving access to medicines, including activities to eliminate NTDs and malaria, go beyond the framework of CSR activities and aim at creating long-term value and social impact based on our corporate concept, human health care (hhc). We aim to contribute to relieving anxiety over health and reducing health disparities of people at risk of contracting neglected tropical diseases and those suffering from diseases by strengthening our global partnerships. 

About the Volunteer Group of Business Leaders Supporting Global Health

The Volunteer Group is an organization of Japanese companies and others contributing to global health (supporting and actively working in the fields of healthcare, especially public health and infectious disease control), led by Ken Shibusawa (CEO, Shibusawa & Company, Inc.). It is composed of executives from a wide variety of fields, including not only the healthcare sector, such as pharmaceuticals and medical devices, but also finance, trading, digital, supply chain, and more. Haruo Naito, Eisai’s CEO, is a member.
   The Volunteer Group believes that by optimizing the products and technologies of diverse sectors, including governments, we can provide comprehensive solutions to global issues, and to this end, the volunteer companies will work together under the same vision to promote Global Health Action. The Volunteer Group is considering the following four initiatives for the future. (Not all volunteer companies will participate in these initiatives.)

  • 1.
    Consider specialized schemes and entities that promote the creation and strengthening of opportunities to collaborate with international health organizations such as WHO, Global Fund, Gavi Vaccine Alliance, etc.
  • 2.
    Establish an All-Japan pavilion at international exhibitions and promotion of the advanced and attractive features of Japanese products that contribute to global health
  • 3.
    Promote the introduction and participation in a system of "impact-weighted accounting" that quantifies and visualizes the impact of socially conscious products
  • 4.
    Continue activities to bring corporate voices on international health issues to the government 

Related Links